pancreatic dysfunction
Recently Published Documents


TOTAL DOCUMENTS

131
(FIVE YEARS 34)

H-INDEX

22
(FIVE YEARS 3)

2022 ◽  
Vol 23 (2) ◽  
pp. 864
Author(s):  
Urszula Abramczyk ◽  
Maciej Nowaczyński ◽  
Adam Słomczyński ◽  
Piotr Wojnicz ◽  
Piotr Zatyka ◽  
...  

Although coronavirus disease 2019 (COVID-19)-related major health consequences involve the lungs, a growing body of evidence indicates that COVID-19 is not inert to the pancreas either. This review presents a summary of the molecular mechanisms involved in the development of pancreatic dysfunction during the course of COVID-19, the comparison of the effects of non-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on pancreatic function, and a summary of how drugs used in COVID-19 treatment may affect this organ. It appears that diabetes is not only a condition that predisposes a patient to suffer from more severe COVID-19, but it may also develop as a consequence of infection with this virus. Some SARS-CoV-2 inpatients experience acute pancreatitis due to direct infection of the tissue with the virus or due to systemic multiple organ dysfunction syndrome (MODS) accompanied by elevated levels of amylase and lipase. There are also reports that reveal a relationship between the development and treatment of pancreatic cancer and SARS-CoV-2 infection. It has been postulated that evaluation of pancreatic function should be increased in post-COVID-19 patients, both adults and children.


2021 ◽  
Vol 225 ◽  
pp. 112802
Author(s):  
Shiyao Zhang ◽  
Mengyi Xu ◽  
Ziyue Shen ◽  
Changrui Shang ◽  
Wenxiang Zhang ◽  
...  

Pancreatology ◽  
2021 ◽  
Author(s):  
Anam Khan ◽  
Santhi Swaroop Vege ◽  
Vikas Dudeja ◽  
Suresh T. Chari

2021 ◽  
Vol 23 (2) ◽  
pp. 319-326
Author(s):  
Marina A. Lyadova ◽  
Vladimir K. Lyadov

Immune-mediated adverse events (imAEs) are complications of therapy with immune checkpoint inhibitors, which arise as a result of autoimmune inflammation. The article summarizes systemic (fatigue, fever), cutaneous (rash, itching), gastrointestinal (diarrhea, colitis, hepatitis, pancreatic dysfunction), endocrinological (hypothyroidism, hypophysitis, adrenal insufficiency, diabetes mellitus), pulmonary (pneumonitis, pleuritis), rheumatological (arthralgia), neurological (headache, sensory and motor disorders), renal (acute interstitial nephritis, lupus-like nephritis, granulomatous nephritis, diffuse interstitial nephritis and minimal change disease), hematological (anemia, cytopenia), cardiovascular (myocarditis) and ocular (conjunctivitis, episcleritis, ceratitis, blepharitis and uveitis) imAE. Pathogenetic mechanisms and treatment approaches (in accordance with toxicity grade and clinical recommendations) are discussed. Early symptom recognition, patient education and timely intervention are crucial for imAE correction.


REPORTS ◽  
2021 ◽  
Vol 4 (338) ◽  
pp. 21-30
Author(s):  
S.N. Abdreshov ◽  
Sh.S. Snynybekova ◽  
E.S. Boribai ◽  
N.A. Rachmetulla ◽  
S.E. Seralieva

Pancreatology ◽  
2021 ◽  
Vol 21 ◽  
pp. S22
Author(s):  
S. Leal-Lopez ◽  
M.J. Otero-Fraga ◽  
J. Iglesias-Garcia ◽  
J. Lariño-Noia ◽  
L. Nieto-Garcia ◽  
...  

2021 ◽  
Vol 5 (Supplement_1) ◽  
pp. A379-A380
Author(s):  
Kaley N Breault ◽  
Brittney H Arakaki ◽  
Peminda K Cabandugama ◽  
Jordan M Rowe

Abstract Background: Currently there are no evidence-based medical recommendations to support the use of supplements in type 1 diabetes mellitus (DM), although there is some data that supports glucose lowering in type 2 DM with supplements such as cinnamon. Additionally, there is no evidence regarding the use of supplements in insulin-dependent DM secondary to pancreatic dysfunction from alcohol use disorder. Despite lack of clear evidence, it is estimated that more than 65% of Americans with DM use at least one dietary supplement for perceived health benefits. (1)Clinical Case: A 58-year old male presented with insulin-dependent DM secondary to pancreatic dysfunction from alcohol use disorder. Initial labs were significant for a low C-peptide of 0.13 ng/mL (0.80–3.85 ng/mL), A1c -9.4%, and blood glucoses ranging from 160–300 mg/dL. Patient’s DM regimen consisted of glargine 40 units nightly and aspart 12 units three times a day with meals. On a subsequent visit two months later, the patient stated that he had begun taking numerous supplements in hopes that these would improve his overall medical status. Supplements included Blood Boost Formula, Ultra K2 with MK-7, Chromium Picolinate, Male Enhancement, Super C Immune Complex, Nugenix Total-T, Niacinamide, Omega Q Plus Max, Cortisol Hormone Balancer, and Vitamin D3. Simultaneously, the patient self-discontinued all his maintenance medications except for his aforementioned insulin regimen due to the fear of negatively impacting his pancreas. Unexpectedly, his blood glucoses improved to a range of 90–150 mg/dL after being on these supplements without increasing his insulin dose. Upon literature review, three ingredients showed the most evidence for the possible explanation for his improvement in glucose control: L-arginine, nettle extract, and biotin with chromium. Conclusion: Literature review of in vivo and randomized, placebo-controlled studies demonstrated mechanisms of action for L-arginine, nettle extract, and biotin with chromium that indicate their potential role in lowering blood glucoses and increasing C-peptide levels in insulin-dependent DM secondary to pancreatic dysfunction from alcohol use disorder. Further investigations include exploring long-term impact on pancreatic function, glucose control, and insulin resistance. Reference: (1) Garrow, D., Egede, L. Association Between Complementary and Alternative Medicine Use, Preventive Care Practices, and Use of Conventional Medical Services Among Adults with Diabetes. Diabetes Care 2006 Jan; 29(1): 15–19.


Sign in / Sign up

Export Citation Format

Share Document